Genital Herpes Treatment Market by Type of Drugs (Acyclovir, Famciclovir, Valacyclovir, and Others), Distribution channels (Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies), Route of Administration (Oral and Topical), and Geography – Global Forecast up to 2027
Genital herpes disease is caused due to herpes simplex virus, and it is a sexually transmittable disease or infection (STI). The diagnosis of genital herpes is made from painful blisters on and areas surrounding genitals of both men and women affecting mucus membrane which exist in the body. When compared based on sex, genital herpes is most common among women. Presently no permanent cure has been discovered for genital herpes, which is a chronic condition. Although, medication is available for controlling the triggered symptoms of this disease. The Genital Herpes Treatment Market is anticipated to grow at the rate of 4.1% CAGR by 2027. The key factor projected to accelerate the genital herpes treatment market during the forecast period is escalating demand for effective therapeutic options for the treatment of these infections. Governments worldwide have taken initiatives to address the urgent requirement of better treatment for sexually transmitted infections and to fight the rapid development of antiviral-resistant species, which would support the growth of the genital herpes treatment market. However, the huge expenses incurred in the treatment of genital herpes treatment are likely to hamper the market growth.
Genital Herpes Treatment Market on the basis of Type of Drugs
Further on the basis of distribution channel, the genital herpes treatment market has been classified into hospital pharmacies, retail pharmacies, drug stores, and online pharmacies. Among all of the distribution channels, the online pharmacies segment is projected to acquire a maximum share in the market. This is due to the increasing number of online pharmacy websites for the drugs which offer various discounts and growing customer preference for online pharmacies for drugs pushing for the segment growth.
On the basis of route of administration, the genital herpes treatment market is bifurcated into oral and topical. The oral administration route segment has a major share in the market. This is due to customer preference for oral treatment, facilitated by application ease and effectiveness.
As per the market by geography, the market is categorized into North America, Europe, Asia Pacific, and the rest of the world. North America region made a substantial contribution in the market. This is majorly due to the increasing patients’ awareness, better infrastructure, and relatively higher cost of treatment in the region.
The rising prevalence of sexually transmitted diseases, changing socio-cultural openness, and growing awareness are projected to boost the demand for genital herpes treatment over the forecast period. For instance, as per the center for disease control and prevention, approximately 50 million people affected with genital herpes in the U.S. Factors such as increasing diagnosis rate in developing countries and increasing clinical trial of vaccines for genital herpes has also propelled the growth of the global genital herpes treatment market during the forecast period.
The major leading companies of the genital herpes treatment market are Novopharm Ltd., Teva Pharmaceuticals Inc., Dr. Reddy’s Laboratories Ltd., Genocea Biosciences, Mylan Pharmaceuticals Inc., Apotheca Inc., GlaxoSmithKline, Sandoz Inc., Novartis AG, Hospira Inc.
Genital herpes is a disease, which does not have a complete treatment, but the medications are available which are playing a crucial part in suppressing the frequency and quantity of genital herpes among people. Moreover, the awareness has increased among people regarding genital herpes has increased the market demand.
Genital Herpes Treatment Market on the basis of Type of Drugs
- Acyclovir
- Famciclovir
- Valacyclovir
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Drug stores
- Online Pharmacies
- Oral
- Topical
- North America
- Europe
- Asia Pacific
- Rest of the World
Further on the basis of distribution channel, the genital herpes treatment market has been classified into hospital pharmacies, retail pharmacies, drug stores, and online pharmacies. Among all of the distribution channels, the online pharmacies segment is projected to acquire a maximum share in the market. This is due to the increasing number of online pharmacy websites for the drugs which offer various discounts and growing customer preference for online pharmacies for drugs pushing for the segment growth.
On the basis of route of administration, the genital herpes treatment market is bifurcated into oral and topical. The oral administration route segment has a major share in the market. This is due to customer preference for oral treatment, facilitated by application ease and effectiveness.
As per the market by geography, the market is categorized into North America, Europe, Asia Pacific, and the rest of the world. North America region made a substantial contribution in the market. This is majorly due to the increasing patients’ awareness, better infrastructure, and relatively higher cost of treatment in the region.
The rising prevalence of sexually transmitted diseases, changing socio-cultural openness, and growing awareness are projected to boost the demand for genital herpes treatment over the forecast period. For instance, as per the center for disease control and prevention, approximately 50 million people affected with genital herpes in the U.S. Factors such as increasing diagnosis rate in developing countries and increasing clinical trial of vaccines for genital herpes has also propelled the growth of the global genital herpes treatment market during the forecast period.
The major leading companies of the genital herpes treatment market are Novopharm Ltd., Teva Pharmaceuticals Inc., Dr. Reddy’s Laboratories Ltd., Genocea Biosciences, Mylan Pharmaceuticals Inc., Apotheca Inc., GlaxoSmithKline, Sandoz Inc., Novartis AG, Hospira Inc.
Genital herpes is a disease, which does not have a complete treatment, but the medications are available which are playing a crucial part in suppressing the frequency and quantity of genital herpes among people. Moreover, the awareness has increased among people regarding genital herpes has increased the market demand.
- The study offers a thorough analysis of the genital herpes treatment market size along with the present trends and forthcoming estimations to describe the impending investment pockets.
- It also offers the genital herpes treatment market analysis over the forecast period, which is projected to allow the shareholders to benefit from the market opportunities.
- Comprehensive insights of the four major regions are depicted to determine the potential opportunities.
- The profiles and dynamic strategies of the major competitors are completely analyzed to understand the competitive outlook and global genital herpes treatment market growth.
1. EXECUTIVE SUMMARY
2. INDUSTRY OUTLOOK
2.1. Industry Overview
2.2. Industry Trends
3. MARKET SNAPSHOT
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. MARKET CHARACTERISTICS
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. TYPE OF DRUGS: MARKET SIZE & ANALYSIS
5.1. Overview
5.2. Acyclovir
5.3. Famciclovir
5.4. Valacyclovir
5.5. Others
6. DISTRIBUTION CHANNELS: MARKET SIZE & ANALYSIS
6.1. Overview
6.2. Hospital Pharmacies
6.3. Retail Pharmacies
6.4. Drug stores
6.5. Online Pharmacies
7. ROUTE OF ADMINISTRATION: MARKET SIZE & ANALYSIS
7.1. Overview
7.2. Oral
7.3. Topical
8. GEOGRAPHY: MARKET SIZE & ANALYSIS
8.1. Overview
8.2. North America
8.3. Europe
8.4. Asia Pacific
8.5. Rest of the World
9. COMPETITIVE LANDSCAPE
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. VENDOR PROFILES
10.1. Novopharm Ltd.
10.1.1. Overview
10.1.2. Financial Overview
10.1.3. Product Offerings
10.1.4. Developments
10.1.5. Business Strategy
10.2. Teva Pharmaceuticals Inc.
10.2.1. Overview
10.2.2. Financial Overview
10.2.3. Product Offerings
10.2.4. Developments
10.2.5. Business Strategy
10.3. Dr. Reddy’s Laboratories Ltd.
10.3.1. Overview
10.3.2. Financial Overview
10.3.3. Product Offerings
10.3.4. Developments
10.3.5. Business Strategy
10.4. Genocea Biosciences
10.4.1. Overview
10.4.2. Financial Overview
10.4.3. Product Offerings
10.4.4. Developments
10.4.5. Business Strategy
10.5. Mylan Pharmaceuticals Inc.
10.5.1. Overview
10.5.2. Financial Overview
10.5.3. Product Offerings
10.5.4. Developments
10.5.5. Business Strategy
10.6. Apotheca Inc.
10.6.1. Overview
10.6.2. Financial Overview
10.6.3. Product Offerings
10.6.4. Developments
10.6.5. Business Strategy
10.7. GlaxoSmithKline
10.7.1. Overview
10.7.2. Financial Overview
10.7.3. Product Offerings
10.7.4. Developments
10.7.5. Business Strategy
10.8. Sandoz Inc.
10.8.1. Overview
10.8.2. Financial Overview
10.8.3. Product Offerings
10.8.4. Developments
10.8.5. Business Strategy
10.9. Novartis AG
10.9.1. Overview
10.9.2. Financial Overview
10.9.3. Product Offerings
10.9.4. Developments
10.9.5. Business Strategy
10.10. Hospira Inc.
10.10.1. Overview
10.10.2. Financial Overview
10.10.3. Product Offerings
10.10.4. Developments
10.10.5. Business Strategy
11. ANALYST OPINION
12. ANNEXURE
12.1. Report Scope
12.2. Market Definitions
12.3. Research Methodology
12.3.1. Data Collation and In-house Estimation
12.3.2. Market Triangulation
12.3.3. Forecasting
12.4. Report Assumptions
12.5. Declarations
12.6. Stakeholders
12.7. Abbreviations
2. INDUSTRY OUTLOOK
2.1. Industry Overview
2.2. Industry Trends
3. MARKET SNAPSHOT
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. MARKET CHARACTERISTICS
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. TYPE OF DRUGS: MARKET SIZE & ANALYSIS
5.1. Overview
5.2. Acyclovir
5.3. Famciclovir
5.4. Valacyclovir
5.5. Others
6. DISTRIBUTION CHANNELS: MARKET SIZE & ANALYSIS
6.1. Overview
6.2. Hospital Pharmacies
6.3. Retail Pharmacies
6.4. Drug stores
6.5. Online Pharmacies
7. ROUTE OF ADMINISTRATION: MARKET SIZE & ANALYSIS
7.1. Overview
7.2. Oral
7.3. Topical
8. GEOGRAPHY: MARKET SIZE & ANALYSIS
8.1. Overview
8.2. North America
8.3. Europe
8.4. Asia Pacific
8.5. Rest of the World
9. COMPETITIVE LANDSCAPE
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. VENDOR PROFILES
10.1. Novopharm Ltd.
10.1.1. Overview
10.1.2. Financial Overview
10.1.3. Product Offerings
10.1.4. Developments
10.1.5. Business Strategy
10.2. Teva Pharmaceuticals Inc.
10.2.1. Overview
10.2.2. Financial Overview
10.2.3. Product Offerings
10.2.4. Developments
10.2.5. Business Strategy
10.3. Dr. Reddy’s Laboratories Ltd.
10.3.1. Overview
10.3.2. Financial Overview
10.3.3. Product Offerings
10.3.4. Developments
10.3.5. Business Strategy
10.4. Genocea Biosciences
10.4.1. Overview
10.4.2. Financial Overview
10.4.3. Product Offerings
10.4.4. Developments
10.4.5. Business Strategy
10.5. Mylan Pharmaceuticals Inc.
10.5.1. Overview
10.5.2. Financial Overview
10.5.3. Product Offerings
10.5.4. Developments
10.5.5. Business Strategy
10.6. Apotheca Inc.
10.6.1. Overview
10.6.2. Financial Overview
10.6.3. Product Offerings
10.6.4. Developments
10.6.5. Business Strategy
10.7. GlaxoSmithKline
10.7.1. Overview
10.7.2. Financial Overview
10.7.3. Product Offerings
10.7.4. Developments
10.7.5. Business Strategy
10.8. Sandoz Inc.
10.8.1. Overview
10.8.2. Financial Overview
10.8.3. Product Offerings
10.8.4. Developments
10.8.5. Business Strategy
10.9. Novartis AG
10.9.1. Overview
10.9.2. Financial Overview
10.9.3. Product Offerings
10.9.4. Developments
10.9.5. Business Strategy
10.10. Hospira Inc.
10.10.1. Overview
10.10.2. Financial Overview
10.10.3. Product Offerings
10.10.4. Developments
10.10.5. Business Strategy
11. ANALYST OPINION
12. ANNEXURE
12.1. Report Scope
12.2. Market Definitions
12.3. Research Methodology
12.3.1. Data Collation and In-house Estimation
12.3.2. Market Triangulation
12.3.3. Forecasting
12.4. Report Assumptions
12.5. Declarations
12.6. Stakeholders
12.7. Abbreviations
LIST OF TABLES
TABLE 1. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 2. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR ACYCLOVIR, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 3. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR FAMCICLOVIR, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 4. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR VALACYCLOVIR, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 5. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 6. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 7. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR HOSPITAL PHARMACIES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 8. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR RETAIL PHARMACIES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 9. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR DRUG STORES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 10. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR ONLINE PHARMACIES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 11. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 12. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR ORAL, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 13. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR TOPICAL, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 14. NORTH AMERICA GENITAL HERPES TREATMENT MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 15. NORTH AMERICA GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 16. NORTH AMERICA GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
TABLE 17. NORTH AMERICA GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 18. U.S GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 19. U.S GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
TABLE 20. U.S GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 21. CANADA GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 22. CANADA GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
TABLE 23. CANADA GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 24. EUROPE GENITAL HERPES TREATMENT MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 25. EUROPE GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 26. EUROPE GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
TABLE 27. EUROPE GENITAL HERPES TREATMENT MARKET VALUE, ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 28. GERMANY GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 29. GERMANY GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
TABLE 30. GERMANY GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 31. U.K GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 32. U.K GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
TABLE 33. U.K GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 34. FRANCE GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 35. FRANCE GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
TABLE 36. FRANCE GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 37. ITALY GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 38. ITALY GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
TABLE 39. ITALY GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 40. SPAIN GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 41. SPAIN GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
TABLE 42. SPAIN GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 43. ROE GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 44. ROE GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
TABLE 45. ROE GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 46. ASIA PACIFIC GENITAL HERPES TREATMENT MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 47. ASIA PACIFIC GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 48. ASIA PACIFIC GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
TABLE 49. ASIA PACIFIC GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 50. CHINA GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 51. CHINA GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
TABLE 52. CHINA GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 53. INDIA GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 54. INDIA GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
TABLE 55. INDIA GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 56. JAPAN GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 57. JAPAN GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
TABLE 58. JAPAN GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 59. REST OF APAC GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 60. REST OF APAC GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
TABLE 61. REST OF APAC GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 62. REST OF WORLD GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 63. REST OF WORLD GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
TABLE 64. REST OF WORLD GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 65. NOVOPHARM LTD.: FINANCIALS
TABLE 66. NOVOPHARM LTD.: PRODUCTS & SERVICES
TABLE 67. NOVOPHARM LTD.: RECENT DEVELOPMENTS
TABLE 68. TEVA PHARMACEUTICALS INC.: FINANCIALS
TABLE 69. TEVA PHARMACEUTICALS INC.: PRODUCTS & SERVICES
TABLE 70. TEVA PHARMACEUTICALS INC.: RECENT DEVELOPMENTS
TABLE 71. DR. REDDY’S LABORATORIES LTD: FINANCIALS
TABLE 72. DR. REDDY’S LABORATORIES LTD: PRODUCTS & SERVICES
TABLE 73. DR. REDDY’S LABORATORIES LTD: RECENT DEVELOPMENTS
TABLE 74. GENOCEA BIOSCIENCES: FINANCIALS
TABLE 75. GENOCEA BIOSCIENCES: PRODUCTS & SERVICES
TABLE 76. GENOCEA BIOSCIENCES: RECENT DEVELOPMENTS
TABLE 77. MYLAN PHARMACEUTICALS INC: FINANCIALS
TABLE 78. MYLAN PHARMACEUTICALS INC: PRODUCTS & SERVICES
TABLE 79. MYLAN PHARMACEUTICALS INC: RECENT DEVELOPMENTS
TABLE 80. APOTHECA INC: FINANCIALS
TABLE 81. APOTHECA INC: PRODUCTS & SERVICES
TABLE 82. APOTHECA INC: RECENT DEVELOPMENTS
TABLE 83. GLAXOSMITHKLINE: FINANCIALS
TABLE 84. GLAXOSMITHKLINE: PRODUCTS & SERVICES
TABLE 85. GLAXOSMITHKLINE: RECENT DEVELOPMENTS
TABLE 86. SANDOZ INC: FINANCIALS
TABLE 87. SANDOZ INC: PRODUCTS & SERVICES
TABLE 88. SANDOZ INC: RECENT DEVELOPMENTS
TABLE 89. NOVARTIS AG: FINANCIALS
TABLE 90. NOVARTIS AG: PRODUCTS & SERVICES
TABLE 91. NOVARTIS AG: RECENT DEVELOPMENTS
TABLE 92. HOSPIRA INC: FINANCIALS
TABLE 93. HOSPIRA INC: PRODUCTS & SERVICES
TABLE 94. HOSPIRA INC: RECENT DEVELOPMENTS
TABLE 1. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 2. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR ACYCLOVIR, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 3. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR FAMCICLOVIR, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 4. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR VALACYCLOVIR, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 5. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 6. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 7. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR HOSPITAL PHARMACIES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 8. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR RETAIL PHARMACIES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 9. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR DRUG STORES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 10. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR ONLINE PHARMACIES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 11. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 12. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR ORAL, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 13. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR TOPICAL, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 14. NORTH AMERICA GENITAL HERPES TREATMENT MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 15. NORTH AMERICA GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 16. NORTH AMERICA GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
TABLE 17. NORTH AMERICA GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 18. U.S GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 19. U.S GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
TABLE 20. U.S GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 21. CANADA GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 22. CANADA GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
TABLE 23. CANADA GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 24. EUROPE GENITAL HERPES TREATMENT MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 25. EUROPE GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 26. EUROPE GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
TABLE 27. EUROPE GENITAL HERPES TREATMENT MARKET VALUE, ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 28. GERMANY GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 29. GERMANY GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
TABLE 30. GERMANY GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 31. U.K GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 32. U.K GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
TABLE 33. U.K GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 34. FRANCE GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 35. FRANCE GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
TABLE 36. FRANCE GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 37. ITALY GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 38. ITALY GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
TABLE 39. ITALY GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 40. SPAIN GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 41. SPAIN GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
TABLE 42. SPAIN GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 43. ROE GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 44. ROE GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
TABLE 45. ROE GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 46. ASIA PACIFIC GENITAL HERPES TREATMENT MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 47. ASIA PACIFIC GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 48. ASIA PACIFIC GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
TABLE 49. ASIA PACIFIC GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 50. CHINA GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 51. CHINA GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
TABLE 52. CHINA GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 53. INDIA GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 54. INDIA GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
TABLE 55. INDIA GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 56. JAPAN GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 57. JAPAN GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
TABLE 58. JAPAN GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 59. REST OF APAC GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 60. REST OF APAC GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
TABLE 61. REST OF APAC GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 62. REST OF WORLD GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
TABLE 63. REST OF WORLD GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
TABLE 64. REST OF WORLD GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
TABLE 65. NOVOPHARM LTD.: FINANCIALS
TABLE 66. NOVOPHARM LTD.: PRODUCTS & SERVICES
TABLE 67. NOVOPHARM LTD.: RECENT DEVELOPMENTS
TABLE 68. TEVA PHARMACEUTICALS INC.: FINANCIALS
TABLE 69. TEVA PHARMACEUTICALS INC.: PRODUCTS & SERVICES
TABLE 70. TEVA PHARMACEUTICALS INC.: RECENT DEVELOPMENTS
TABLE 71. DR. REDDY’S LABORATORIES LTD: FINANCIALS
TABLE 72. DR. REDDY’S LABORATORIES LTD: PRODUCTS & SERVICES
TABLE 73. DR. REDDY’S LABORATORIES LTD: RECENT DEVELOPMENTS
TABLE 74. GENOCEA BIOSCIENCES: FINANCIALS
TABLE 75. GENOCEA BIOSCIENCES: PRODUCTS & SERVICES
TABLE 76. GENOCEA BIOSCIENCES: RECENT DEVELOPMENTS
TABLE 77. MYLAN PHARMACEUTICALS INC: FINANCIALS
TABLE 78. MYLAN PHARMACEUTICALS INC: PRODUCTS & SERVICES
TABLE 79. MYLAN PHARMACEUTICALS INC: RECENT DEVELOPMENTS
TABLE 80. APOTHECA INC: FINANCIALS
TABLE 81. APOTHECA INC: PRODUCTS & SERVICES
TABLE 82. APOTHECA INC: RECENT DEVELOPMENTS
TABLE 83. GLAXOSMITHKLINE: FINANCIALS
TABLE 84. GLAXOSMITHKLINE: PRODUCTS & SERVICES
TABLE 85. GLAXOSMITHKLINE: RECENT DEVELOPMENTS
TABLE 86. SANDOZ INC: FINANCIALS
TABLE 87. SANDOZ INC: PRODUCTS & SERVICES
TABLE 88. SANDOZ INC: RECENT DEVELOPMENTS
TABLE 89. NOVARTIS AG: FINANCIALS
TABLE 90. NOVARTIS AG: PRODUCTS & SERVICES
TABLE 91. NOVARTIS AG: RECENT DEVELOPMENTS
TABLE 92. HOSPIRA INC: FINANCIALS
TABLE 93. HOSPIRA INC: PRODUCTS & SERVICES
TABLE 94. HOSPIRA INC: RECENT DEVELOPMENTS
LIST OF FIGURES
CHART. 1. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 2. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR ACYCLOVIR, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 3. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR FAMCICLOVIR, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 4. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR VALACYCLOVIR, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 5. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 6. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 7. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR HOSPITAL PHARMACIES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 8. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR RETAIL PHARMACIES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 9. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR DRUG STORES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 10. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR ONLINE PHARMACIES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 11. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
CHART. 12. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR ORAL, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 13. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR TOPICAL, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 14. NORTH AMERICA GENITAL HERPES TREATMENT MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
CHART. 15. NORTH AMERICA GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 16. NORTH AMERICA GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
CHART. 17. NORTH AMERICA GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
CHART. 18. U.S GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 19. U.S GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
CHART. 20. U.S GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
CHART. 21. CANADA GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 22. CANADA GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
CHART. 23. CANADA GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
CHART. 24. EUROPE GENITAL HERPES TREATMENT MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
CHART. 25. EUROPE GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 26. EUROPE GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
CHART. 27. EUROPE GENITAL HERPES TREATMENT MARKET VALUE, ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
CHART. 28. GERMANY GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 29. GERMANY GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
CHART. 30. GERMANY GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
CHART. 31. U.K GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 32. U.K GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
CHART. 33. U.K GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
CHART. 34. FRANCE GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 35. FRANCE GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
CHART. 36. FRANCE GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
CHART. 37. ITALY GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 38. ITALY GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
CHART. 39. ITALY GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
CHART. 40. SPAIN GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 41. SPAIN GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
CHART. 42. SPAIN GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
CHART. 43. ROE GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 44. ROE GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
CHART. 45. ROE GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
CHART. 46. ASIA PACIFIC GENITAL HERPES TREATMENT MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
CHART. 47. ASIA PACIFIC GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 48. ASIA PACIFIC GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
CHART. 49. ASIA PACIFIC GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
CHART. 50. CHINA GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 51. CHINA GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
CHART. 52. CHINA GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
CHART. 53. INDIA GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 54. INDIA GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
CHART. 55. INDIA GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
CHART. 56. JAPAN GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 57. JAPAN GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
CHART. 58. JAPAN GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
CHART. 59. REST OF APAC GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 60. REST OF APAC GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
CHART. 61. REST OF APAC GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
CHART. 62. REST OF WORLD GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 63. REST OF WORLD GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
CHART. 64. REST OF WORLD GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
CHART. 1. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 2. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR ACYCLOVIR, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 3. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR FAMCICLOVIR, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 4. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR VALACYCLOVIR, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 5. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 6. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 7. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR HOSPITAL PHARMACIES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 8. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR RETAIL PHARMACIES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 9. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR DRUG STORES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 10. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR ONLINE PHARMACIES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 11. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
CHART. 12. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR ORAL, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 13. GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR TOPICAL, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 14. NORTH AMERICA GENITAL HERPES TREATMENT MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
CHART. 15. NORTH AMERICA GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 16. NORTH AMERICA GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
CHART. 17. NORTH AMERICA GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
CHART. 18. U.S GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 19. U.S GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
CHART. 20. U.S GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
CHART. 21. CANADA GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 22. CANADA GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
CHART. 23. CANADA GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
CHART. 24. EUROPE GENITAL HERPES TREATMENT MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
CHART. 25. EUROPE GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 26. EUROPE GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
CHART. 27. EUROPE GENITAL HERPES TREATMENT MARKET VALUE, ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
CHART. 28. GERMANY GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 29. GERMANY GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
CHART. 30. GERMANY GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
CHART. 31. U.K GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 32. U.K GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
CHART. 33. U.K GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
CHART. 34. FRANCE GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 35. FRANCE GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
CHART. 36. FRANCE GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
CHART. 37. ITALY GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 38. ITALY GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
CHART. 39. ITALY GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
CHART. 40. SPAIN GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 41. SPAIN GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
CHART. 42. SPAIN GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
CHART. 43. ROE GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 44. ROE GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
CHART. 45. ROE GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
CHART. 46. ASIA PACIFIC GENITAL HERPES TREATMENT MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
CHART. 47. ASIA PACIFIC GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 48. ASIA PACIFIC GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
CHART. 49. ASIA PACIFIC GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
CHART. 50. CHINA GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 51. CHINA GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
CHART. 52. CHINA GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
CHART. 53. INDIA GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 54. INDIA GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
CHART. 55. INDIA GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
CHART. 56. JAPAN GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 57. JAPAN GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
CHART. 58. JAPAN GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
CHART. 59. REST OF APAC GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 60. REST OF APAC GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
CHART. 61. REST OF APAC GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
CHART. 62. REST OF WORLD GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)
CHART. 63. REST OF WORLD GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)
CHART. 64. REST OF WORLD GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)
